Olegs received his master’s degree in molecular biology and genetics from the University of Liverpool (UK). During his degree, he also worked in R&D for the antibody development company RANDOX. He then joined the THERADNET network as a PhD researcher in the OncoRay Institute (Germany). Olegs’ project focuses on the investigation of the interconnection of integrins, cell adhesion proteins, and nucleus architecture and organization in response to DNA damage. Identification of the role of integrins in the nucleus and DNA damage regulation gives an opportunity to find more ways to fight cancer.